Health, politics and access
This article discusses the approval of a new dengue vaccine in India and explores the intersection of public health, government policy, and social justice. It highlights how health issues are often linked to broader political and social crises, such as hunger strikes and medical access for marginalized groups.
Why it matters
It underscores the necessity of combining scientific innovation with equitable policy to address systemic public health challenges in India.
Dengue vaccine approval, protests, healthcare access, climate-linked crises and more
Vaccination remains one of modern public health’s greatest achievements, preventing millions of deaths and substantially reducing the burden of infectious diseases. But scientific breakthroughs alone are not enough, their impact depends on strong regulation, affordability and equitable access.
India’s approval of dengue vaccine for individuals aged 4 to 60 years is therefore one of the week’s most significant health developments. The Drug Controller General of India has authorised Takeda’s two-dose QDENGA vaccine , which protects against all four dengue virus serotypes and can be given without prior dengue screening. As dengue continues to place a heavy burden on India, the approval adds an important preventive tool. Read this explainer to know all about the vaccine.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in